These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 20947401)
1. Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families. Hietala M; Henningson M; Törngren T; Olsson H; Jernström H Mol Genet Metab; 2011 Jan; 102(1):82-90. PubMed ID: 20947401 [TBL] [Abstract][Full Text] [Related]
2. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women. Hietala M; Sandberg T; Borg A; Olsson H; Jernström H Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022 [TBL] [Abstract][Full Text] [Related]
4. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399 [TBL] [Abstract][Full Text] [Related]
5. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families. Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype. Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104 [TBL] [Abstract][Full Text] [Related]
7. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Spurdle AB; Antoniou AC; Duffy DL; Pandeya N; Kelemen L; Chen X; Peock S; Cook MR; Smith PL; Purdie DM; Newman B; Dite GS; Apicella C; Southey MC; Giles GG; Hopper JL; Chenevix-Trench G; Easton DF; Breast Cancer Res; 2005; 7(2):R176-83. PubMed ID: 15743497 [TBL] [Abstract][Full Text] [Related]
8. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study. Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380 [TBL] [Abstract][Full Text] [Related]
9. IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer. Henningson M; Hietala M; Törngren T; Olsson H; Jernström H Fam Cancer; 2011 Jun; 10(2):173-85. PubMed ID: 21113804 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055 [TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M; Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility. Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955 [TBL] [Abstract][Full Text] [Related]
13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ; J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670 [TBL] [Abstract][Full Text] [Related]
14. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Rebbeck TR; Kantoff PW; Krithivas K; Neuhausen S; Blackwood MA; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Weber BL; Brown M Am J Hum Genet; 1999 May; 64(5):1371-7. PubMed ID: 10205268 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. Westberg L; Baghaei F; Rosmond R; Hellstrand M; Landén M; Jansson M; Holm G; Björntorp P; Eriksson E J Clin Endocrinol Metab; 2001 Jun; 86(6):2562-8. PubMed ID: 11397855 [TBL] [Abstract][Full Text] [Related]
16. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene. González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127 [TBL] [Abstract][Full Text] [Related]
17. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer. Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696 [TBL] [Abstract][Full Text] [Related]
18. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels. Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Terry KL; De Vivo I; Titus-Ernstoff L; Shih MC; Cramer DW Cancer Res; 2005 Jul; 65(13):5974-81. PubMed ID: 15994977 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite profile in hormonal receptor genes associated with breast cancer. Iobagiu C; Lambert C; Normand M; Genin C Breast Cancer Res Treat; 2006 Jan; 95(2):153-9. PubMed ID: 16317584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]